Published on
May 31, 2022
- 11:14 GMT
MVision AI Receives FDA Clearance for Guideline-Based Segmentation Software
MVision AI announces that it receives 510(k) clearance from the FDA for guideline-based, AI-powered software for automatic segmentation for radiotherapy. HELSINKI, FINLAND, May 31, 2022 /EINPresswire.com/ -- MVision AI announces that it receives 510(k) …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
